AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...

BofA notes that AstraZeneca (AZN) shares are down greater than 10% in the last few days on the back of China concerns around the ongoing ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

A fraud investigation linked to AstraZeneca (NASDAQ:AZN) has expanded to several government agencies, implicating dozens of senior executives at the company as of last week, Shanghai-based business ...

AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company said its lead product candidate ...

Strengthened institutional and financial systems are crucial for fostering climate resilience and sustainable development in Guinea-Bissau, according to the newly launched Country Climate and ...

The FTSE 100 closed down 49.53 points at 8110.10. Among firms with updates today are Shell, Sainsbury's, Vodafone, Ocado, ...

AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating with Chinese authorities.

In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to ...